Literature DB >> 11864203

Multiresistant Pseudomonas aeruginosa serogroup O:11 outbreak in an intensive care unit.

Panayotis T. Tassios1, Vassiliki Gennimata, Lemonia Spaliara-Kalogeropoulou, Dimitris Kairis, Chryssa Koutsia, Alkiviadis C. Vatopoulos, Nicholas J. Legakis.   

Abstract

OBJECTIVE: To determine whether 15 multiresistant Pseudomonas aeruginosa isolates from an intensive care unit (ICU) outbreak were related, were endemic, and belonged to the O:12 European clone.
METHODS: Forty-six P. aeruginosa isolates from a large hospital were investigated with respect to their antibiotic resistance profiles, serogroups, bacteriocin types and DNA fingerprints obtained by pulsed-field gel electrophoresis (PFGE) of genomic DNA digested with Xbal.
RESULTS: Fourteen of the ICU outbreak isolates were indeed identical with respect to their serogroup, O:11, pyocin type, 10/a, and PFGE type, A. Clone A was endemic and dominant throughout the hospital, even though, within the ICU, it underwent phenotypic alterations, such as loss of cell wall lipopolysaccharide side-chains, or acquisition of ceftazidime and imipenem resistance. Bacteriocin typing was more discriminatory than serotyping, but PFGE could differentiate further among phenotypically identical strains. It also allowed the tracking of an O:6 strain, as it was becoming gradually more resistant and undergoing a bacteriocin-type conversion while remaining genotypically unaltered.
CONCLUSIONS: Using three typing methods, a nosocomial multiresistant strain distinct from the previously described dominant European O:12 clone was characterized, and the ability of PFGE to identify clonal isolates even when these appear phenotypically distinct was demonstrated.

Entities:  

Year:  1997        PMID: 11864203     DOI: 10.1111/j.1469-0691.1997.tb00468.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  6 in total

1.  Spread of multidrug-resistant Pseudomonas aeruginosa clones in a university hospital.

Authors:  Maria Koutsogiannou; Eleanna Drougka; Apostolos Liakopoulos; Eleni Jelastopulu; Efthimia Petinaki; Evangelos D Anastassiou; Iris Spiliopoulou; Myrto Christofidou
Journal:  J Clin Microbiol       Date:  2012-12-12       Impact factor: 5.948

2.  Emergence of multidrug resistance in ubiquitous and dominant Pseudomonas aeruginosa serogroup O:11. The Greek Pseudomonas Aeruginosa Study Group.

Authors:  P T Tassios; V Gennimata; A N Maniatis; C Fock; N J Legakis
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948

Review 3.  Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa in an endemic area: comparison with global data.

Authors:  Theodoros Karampatakis; Charalampos Antachopoulos; Athanassios Tsakris; Emmanuel Roilides
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-04-11       Impact factor: 3.267

4.  Bacterial resistance to ciprofloxacin in Greece: results from the National Electronic Surveillance System. Greek Network for the Surveillance of Antimicrobial Resistance.

Authors:  A C Vatopoulos; V Kalapothaki; N J Legakis
Journal:  Emerg Infect Dis       Date:  1999 May-Jun       Impact factor: 6.883

5.  Structure-function aspects of PstS in multi-drug-resistant Pseudomonas aeruginosa.

Authors:  Olga Zaborina; Christopher Holbrook; Yimei Chen; Jason Long; Alexander Zaborin; Irina Morozova; Hoylan Fernandez; Yingmin Wang; Jerrold R Turner; John C Alverdy
Journal:  PLoS Pathog       Date:  2008-02-08       Impact factor: 6.823

6.  Efficacy of neutral and negatively charged liposome-loaded gentamicin on planktonic bacteria and biofilm communities.

Authors:  Moayad Alhariri; Majed A Majrashi; Ali H Bahkali; Faisal S Almajed; Ali O Azghani; Mohammad A Khiyami; Essam J Alyamani; Sameera M Aljohani; Majed A Halwani
Journal:  Int J Nanomedicine       Date:  2017-09-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.